Finance

Lists
ANTH:OTCMKTS
Anthera Pharmaceuticals Inc
$0.00010
0.00%
(0.00) 1D
Aug 7, 10:00:36 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTH...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
2.62K
Avg. vol.
2.04K
Volume
970.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
2.62K
Avg. vol.
2.04K
Volume
970.00
52-wk high
$0.00
52-wk low
$0.00
Shares outstanding
0.00
No. of employees
21
Profile
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase, Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency is currently in Phase 3 clinical trials, and A-623 for the treatment of IgA nephropathy is currently in Phase 2 clinical trial. Wikipedia
About Anthera Pharmaceuticals Inc
CEO-
Employees21
Founded2004
HeadquartersHayward, California, United States
SectorBiotechnology
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps